NCT00387699View on ClinicalTrials.gov

Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

April 30, 2014

Conditions
Lung Cancer
Interventions
BIOLOGICAL

bevacizumab

DRUG

cisplatin

DRUG

etoposide

RADIATION

radiation therapy

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00387699 - Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter